Literature DB >> 2323864

Relationship between capillary and muscle damage in dermatomyositis.

J Casademont1, J M Grau, R Estruch, J C Pedro-Botet, A Urbano-Márquez.   

Abstract

To assess the pathogenetic importance of capillary damage and its relationship with degenerating muscle fibers in dermatomyositis (DM), an electron microscope study of eight muscle biopsy specimens (adult and juvenile forms) and seven muscle specimens from patients with other neuromuscular diseases was conducted. There was a 49% reduction of capillaries in the muscle specimens of DM patients. Capillary damage also was more frequent in the DM group than in control group (p less than 0.001). We found a striking relation between capillary and muscle damage in the DM group (p less than 0.002) but not in the control group. The diagnostic value of undulating tubules within endothelial cells is also discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2323864     DOI: 10.1111/j.1365-4362.1990.tb04081.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

Review 1.  Polymyositis/dermatomyositis: the current position.

Authors:  A Urbano-Márquez; J Casademont; J M Grau
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

2.  Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.

Authors:  C Dorph; P Englund; I Nennesmo; I E Lundberg
Journal:  Ann Rheum Dis       Date:  2006-07-10       Impact factor: 19.103

3.  The clinicoserological spectrum of inflammatory myopathy in the context of systemic sclerosis and systemic lupus erythematosus.

Authors:  John D Pauling; Sarah Skeoch; Julie J Paik
Journal:  Indian J Rheumatol       Date:  2021-01-18

4.  Disease-associated increased HIF-1, alphavbeta3 integrin, and Flt-1 do not suffice to compensate the damage-inducing loss of blood vessels in inflammatory myopathies.

Authors:  Yrjö T Konttinen; Zygmunt Mackiewicz; Danute Povilenaite; Antti Sukura; Mika Hukkanen; Ismo Virtanen
Journal:  Rheumatol Int       Date:  2003-09-12       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.